Late last year, United Healthcare (UHC)
received national media attention for a stunning announcement: It was returning
medical decision-making to doctors. With few exceptions, the announcement
sparked favorable comments from the physician and public interest communities
and fostered a sense that sanity was returning to managed care.
But the enthusiasm may have been premature.
On the surface the move seems to be a step in the right direction, but time may
prove it to be more problematic than most could imagine.
Epiphany or public relations?
UHC announced that an internal data review
had revealed no significant cost savings from its long-standing
pre-authorization and utilization review protocols. Therefore, doctors would
now be in control of the covered services provided to their patients, and
various forms of preauthorization and approval, at the heart of managed care
since the 1970s, would no longer be used as a means of cost containment.
Some regarded this as an epiphany. Others,
knowing that United and its competitors have had the confirmation data for many
years but chose not to reveal it, are taking a more cynical view. They view
UHC's policy change as little more than hollow and self-serving public
relations timed to deflect the increasingly hostile public perception of HMOs
and the growing turmoil inside the Washington, D.C., Beltway. So why the
announcement, and why now?
HMOs at risk
HMOs are under the gun. They're looking at
the possibility of losing enrollees as the public reaches the breaking point
with horror stories of care denied or care unreasonably limited. They
understand that when the patients lose their patience, employers may also
consider dropping certain health plans. And when the public and employers both
complain loud and often enough, health plans know that legislators may finally
feel pressure to act in ways that might not be HMO-friendly.
And so, in a time of increasing hostility
toward HMOs, calls for patient protections, and demands for the right to sue
health plans, some see UHC's actions as little more than proactive steps
positioning the company to avoid paying out potential litigation settlements.
Critics note that UHC could now point to the doctor and say "It was the
doctor's decision, not ours. Sue him. Sue her."
Between the lines
UHC's turnabout might look good to
practitioners frustrated with the second-guessing and paperwork hassle of
managed care. But those doctors are in for a disappointment if they believe
that medical decision-making won't be questioned and that they're now free to
do whatever they please, whenever they deem it appropriate.
Why? If read carefully, UHC's announcement
reveals some important caveats. Despite saying it's all up to the doctor, UHC
still intends to look at each provider's practice patterns. Rather than using
preauthorizations, UHC now will use retrospective review. The HMO will counsel
doctors whose utilization seems off a norm determined by UHC. And it also
reserves the right to drop any provider if the counseling doesn't produce the
change UHC deems appropriate.
This is ominous and should concern all
surgically conservative physicians. It should also concern those physicians
who, by virtue of superior reputation with primary care physicians,
optometrists, and other physicians, do more surgery or more complex, costly
surgery than most of their colleagues.
The former group may find themselves under
increased pressure from patients to provide procedures that they may not deem
necessary or appropriate at the time. Because the patient knows that UHC has
announced it won't reject any covered procedure recommended by the doctor, that
practitioner will be caught between a rock and a hard place. If the physician
relents to patient pressure, his utilization rates and practice patterns will
rise from previous benchmarks -- and UHC will notice the changes.
And doctors in the latter group, the
surgical gurus already at the high end of the utilization (and cost) scale, may
find that their numbers only go farther into UHC's "red flag" zones
and prompt additional scrutiny and counseling. As a self-protection measure to
avoid deselection, some physicians may have to cut back on procedures. That
could be a lose-lose scenario for patients and providers. And that's only a
sampling of the problems hidden inside this Pandora's Box.
Confounding capitation
Consider what could happen in the case of
networks that now hold master capitation agreements with UHC and subcontract
with ophthalmologists and optometrists. UHC may have announced that it won't
question the doctors, but will its networks who are at risk for a finite pool
of dollars also be precluded from putting appropriate utilization and cost
controls on network doctors?
It's hard to imagine any network saying to
its participating providers: "You're free to do whatever you want,
whenever, and we'll pay for it." To give up that oversight and review
power condemns any capitated entity to a fatal hemorrhaging of its monthly
funds.
The convoluted scenario is nothing short of
a nightmare because to refuse service to a patient when that patient knows UHC
has declared the doctor is "in control" suddenly makes the doctors
(the network) the "bad guys." No longer is the HMO wearing the black
hat. And that critical perceptual change drops enormous collateral damage and
financial pressure onto risk-bearing groups and networks.
Recent news
Despite the "kinder and gentler"
announcement, United has experienced little other than bad news since the
beginning of this year. A sampling:
�
A former vice president
in United's Florida operations filed suit against the company alleging that he
was fired after voicing concern that UHC was deliberately delaying or denying
claims. His suit also contends that the company improperly and routinely
reduced claims payments (downcoding).
�
A lawsuit filed in Mississippi
in February names United in an action alleging racketeering.
�
The American Medical
Association sued United in March, alleging that the HMO used invalid data to
determine reimbursement rates.
Positive points
To UHC's credit, the provider agreements
it's offering this year are a bit less onerous than previous ones. That's not
to say they're physician-friendly in every sense. These agreements still
contain plenty of issues physicians need to negotiate. But the agreements are
getting somewhat better. Here are some specific examples:
�
The influence of newly
enacted prompt payment laws is obvious in new UHC contracts. In those states
with such laws, you'll now find wording stating that claims will be paid within
the statutory limits. And, though not an exact, clear definition of "clean
claim," you'll also find some language detailing the basic information
necessary for prompt processing of your claims.
�
Termination provisions
in the new agreements are more flexible than in the past, and include a
relatively painless "out" clause for physicians who are presented
with unacceptable mid-term amendments.
�
And, in an obvious
response to bad press regarding "gag clauses," new UHC provider
agreements contain the following: Plan encourages Provider to discuss with
Members treatment options and their associated risks and benefits, regardless
of whether the treatment is covered under the Member's Benefit Contract.
Will other HMOs follow?
It will be interesting to see where things
go in the next 18 to 24 months as other plans look at United, at their own
systems and public images, and then react to happenings inside the Beltway. No
one should be surprised if Aetna, Humana, Pacificare, Blue Cross/Blue Shield or
any of the other players suddenly have similar "epiphanies."
To an extent, everyone seems to agree that
physicians should be in charge of the care that they decide is in a patient's
best interests. But it remains to be seen if any healthcare plans actually take
the steps necessary to make that an effective and viable reality.
Gil Weber, M.B.A., is a nationally
recognized author, lecturer and practice management consultant to the managed
care and ophthalmic industries. He has served as managed care director for the
American Academy of Ophthalmology and he's currently a consulting editor to
Ophthalmology Management. You can reach him at (954) 915-6771 or gill@gilweber.com.